Published in Lancet on February 03, 2011
WFPB Lifestyle and Muscle Mass Preservation (WFPBmuscle) | NCT04849689
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 22.33
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06
Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med (2012) 5.98
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ (2012) 5.57
Changing the future of obesity: science, policy, and action. Lancet (2011) 5.56
Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol (2011) 4.68
National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr (2012) 4.13
Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol (2014) 4.00
Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol (2014) 3.99
Molecular mechanisms of cancer development in obesity. Nat Rev Cancer (2011) 3.65
Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab (2012) 3.64
The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol (2013) 3.51
Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Glob Health (2013) 3.49
Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care (2013) 3.43
Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell (2014) 3.27
Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci (2011) 3.15
Modeling causes of death: an integrated approach using CODEm. Popul Health Metr (2012) 3.12
Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol (2012) 3.09
New neighborhood grocery store increased awareness of food access but did not alter dietary habits or obesity. Health Aff (Millwood) (2014) 3.05
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol (2014) 2.88
Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science (2013) 2.85
Estimated Global, Regional, and National Disease Burdens Related to Sugar-Sweetened Beverage Consumption in 2010. Circulation (2015) 2.78
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009. Eur Heart J (2013) 2.74
Stemming the global tsunami of cardiovascular disease. Lancet (2011) 2.54
High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature (2016) 2.50
Morbid obesity rates continue to rise rapidly in the United States. Int J Obes (Lond) (2013) 2.50
Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain. Proc Natl Acad Sci U S A (2013) 2.50
Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study. J Eval Clin Pract (2011) 2.47
Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2011) 2.46
Treatment of obesity with celastrol. Cell (2015) 2.45
Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol (2014) 2.35
Slowing down of adult body mass index trend increases in England: a latent class analysis of cross-sectional surveys (1992-2010). Int J Obes (Lond) (2013) 2.34
The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. Circulation (2013) 2.31
Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab (2013) 2.17
Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev (2014) 2.02
Geographical and socioeconomic inequalities in women and children's nutritional status in Pakistan in 2011: an analysis of data from a nationally representative survey. Lancet Glob Health (2015) 2.01
The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One (2013) 1.95
Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg (2013) 1.91
Lifestyle interventions for overweight and obese pregnant women to improve pregnancy outcome: systematic review and meta-analysis. BMC Med (2012) 1.88
National and subnational mortality effects of metabolic risk factors and smoking in Iran: a comparative risk assessment. Popul Health Metr (2011) 1.81
Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes? Environ Health Perspect (2011) 1.80
Perinatal outcomes after bariatric surgery: nationwide population based matched cohort study. BMJ (2013) 1.79
The weight of nations: an estimation of adult human biomass. BMC Public Health (2012) 1.78
BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis. Hum Reprod Update (2012) 1.75
Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan: a comparative risk assessment. PLoS Med (2012) 1.70
IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice. Hepatology (2014) 1.69
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther (2011) 1.68
Tackling non-communicable diseases in low- and middle-income countries: is the evidence from high-income countries all we need? PLoS Med (2013) 1.67
Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol (2015) 1.66
The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord (2014) 1.64
Nutritional content of supermarket ready meals and recipes by television chefs in the United Kingdom: cross sectional study. BMJ (2012) 1.64
Status of epidemiology in the WHO South-East Asia region: burden of disease, determinants of health and epidemiological research, workforce and training capacity. Int J Epidemiol (2012) 1.63
Children's height and weight in rural and urban populations in low-income and middle-income countries: a systematic analysis of population-representative data. Lancet Glob Health (2013) 1.63
Sleep and obesity. Curr Opin Clin Nutr Metab Care (2011) 1.63
Cryptic genetic variation: evolution's hidden substrate. Nat Rev Genet (2014) 1.61
Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities study. Heart (2014) 1.61
Growth-dependent podocyte failure causes glomerulosclerosis. J Am Soc Nephrol (2012) 1.60
Body mass index as a predictive factor of periodontal therapy outcomes. J Dent Res (2013) 1.55
Prevalence trends in lifestyle-related risk factors. Dtsch Arztebl Int (2015) 1.55
Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARγ activation to decrease diet-induced obesity. Cell Metab (2012) 1.54
Global gender disparities in obesity: a review. Adv Nutr (2012) 1.54
The influence of market deregulation on fast food consumption and body mass index: a cross-national time series analysis. Bull World Health Organ (2014) 1.53
Adipocytokines in obesity and metabolic disease. J Endocrinol (2014) 1.49
Acculturation and obesity among migrant populations in high income countries--a systematic review. BMC Public Health (2013) 1.48
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer (2013) 1.47
Trends in resting pulse rates in 9-11-year-old children in the UK 1980-2008. Arch Dis Child (2013) 1.45
Prenatal risk factors for childhood CKD. J Am Soc Nephrol (2014) 1.45
The immune system as a sensor of the metabolic state. Immunity (2013) 1.45
Does breastfeeding help to reduce the risk of childhood overweight and obesity? A propensity score analysis of data from the KiGGS study. PLoS One (2015) 1.44
Associations between active travel to work and overweight, hypertension, and diabetes in India: a cross-sectional study. PLoS Med (2013) 1.44
Cachexia as a major public health problem: frequent, costly, and deadly. J Cachexia Sarcopenia Muscle (2013) 1.42
Current and predicted prevalence of obesity in Canada: a trend analysis. CMAJ Open (2014) 1.41
Persistent socioeconomic inequalities in cardiovascular risk factors in England over 1994-2008: a time-trend analysis of repeated cross-sectional data. BMC Public Health (2012) 1.41
Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke. PLoS One (2017) 1.40
Physical activity is not related to semen quality in young healthy men. Fertil Steril (2014) 1.40
Untapped potential of health impact assessment. Bull World Health Organ (2013) 1.40
Trend in obesity prevalence in European adult cohort populations during follow-up since 1996 and their predictions to 2015. PLoS One (2011) 1.40
Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents. Int J Endocrinol (2016) 1.40
Urban-rural differences in BMI in low- and middle-income countries: the role of socioeconomic status. Am J Clin Nutr (2013) 1.39
Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. J Immunol (2013) 1.38
An increase in visceral fat is associated with a decrease in the taste and olfactory capacity. PLoS One (2017) 1.38
Freshman 15 in England: a longitudinal evaluation of first year university student's weight change. BMC Obes (2016) 1.38
To Check or Not to Check? A Qualitative Study on How the Public Decides on Health Checks for Cardiovascular Disease Prevention. PLoS One (2016) 1.36
Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord (2013) 1.35
Obesity: overview of an epidemic. Psychiatr Clin North Am (2011) 1.33
Television watching, leisure time physical activity, and the genetic predisposition in relation to body mass index in women and men. Circulation (2012) 1.33
Body configuration as a predictor of mortality: comparison of five anthropometric measures in a 12 year follow-up of the Norwegian HUNT 2 study. PLoS One (2011) 1.32
Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J (2014) 1.32
Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons. Nat Rev Drug Discov (2012) 1.29
Satiety mechanisms in genetic risk of obesity. JAMA Pediatr (2014) 1.29
Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects. EJNMMI Res (2011) 1.29
Dietary and metabolic control of stem cell function in physiology and cancer. Cell Stem Cell (2014) 1.29
Major Findings from The Changing Body: Health, Nutrition, and Human Development in the Western World since 1700. J Econ Asymmetries (2011) 1.29
'Metabolically healthy obesity': origins and implications. Mol Aspects Med (2012) 1.27
Minireview: Epigenetic programming of diabetes and obesity: animal models. Endocrinology (2012) 1.27
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Prevalence and trends in obesity among US adults, 1999-2008. JAMA (2010) 50.58
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70
Selected major risk factors and global and regional burden of disease. Lancet (2002) 24.47
A potential decline in life expectancy in the United States in the 21st century. N Engl J Med (2005) 19.63
A strategy to reduce cardiovascular disease by more than 80%. BMJ (2003) 19.05
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet (2005) 17.08
A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev (2007) 14.60
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48
Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc (2007) 8.48
Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA (2005) 8.07
The public health and economic benefits of taxing sugar-sweetened beverages. N Engl J Med (2009) 7.48
Socioeconomic status and obesity in adult populations of developing countries: a review. Bull World Health Organ (2005) 6.65
The emerging epidemic of obesity in developing countries. Int J Epidemiol (2005) 5.48
Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet (2003) 5.17
Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol (2004) 4.67
Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes (Lond) (2005) 4.41
Mean body weight, height, and body mass index, United States 1960-2002. Adv Data (2004) 4.33
Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med (2006) 4.19
Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet (2007) 4.15
Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med (2007) 3.97
Overweight exceeds underweight among women in most developing countries. Am J Clin Nutr (2005) 3.93
Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes (Lond) (2006) 3.90
Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis. Lancet (2010) 3.89
Downward trends in the prevalence of childhood overweight in the setting of 12-year school- and community-based programmes. Public Health Nutr (2008) 3.53
The predictive value of different measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab (2010) 3.12
Prevalence of obesity in Great Britain. Obes Rev (2005) 3.10
Prevalence of obesity in Taiwan. Obes Rev (2005) 3.08
Educational level, relative body weight, and changes in their association over 10 years: an international perspective from the WHO MONICA Project. Am J Public Health (2000) 3.08
Trends in the distribution of body mass index among Chinese adults, aged 20-45 years (1989-2000). Int J Obes (Lond) (2006) 2.83
Income-specific trends in obesity in Brazil: 1975-2003. Am J Public Health (2007) 2.82
Why is the developed world obese? Annu Rev Public Health (2008) 2.64
Twenty-year changes in the prevalence of overweight in Japanese adults: the National Nutrition Survey 1976-95. Obes Rev (2002) 2.35
Prevalence of obesity in Korea. Obes Rev (2005) 2.27
The obesity pandemic: where have we been and where are we going? Obes Res (2004) 2.24
Is there a lag globally in overweight trends for children compared with adults? Obesity (Silver Spring) (2006) 2.17
Energy intake/physical activity interactions in the homeostasis of body weight regulation. Nutr Rev (2004) 2.10
An epidemic of risk factors for cardiovascular disease. Lancet (2011) 1.99
Trends in overweight by socio-economic status in Vietnam: 1992 to 2002. Public Health Nutr (2007) 1.74
Trends in coronary risk factors in the WHO MONICA project. Int J Epidemiol (2001) 1.61
Decreasing association between body mass index and blood pressure over time. Epidemiology (2007) 1.47
Obesity, diet, and poverty: trends in the Russian transition to market economy. Eur J Clin Nutr (2003) 1.47
Trends in total and high density lipoprotein cholesterol and their determinants in The Netherlands between 1993 and 1997. Int J Epidemiol (2001) 1.29
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (2006) 37.83
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Maternal and child undernutrition: global and regional exposures and health consequences. Lancet (2008) 26.44
Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet (2013) 18.02
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06
Eight Americas: investigating mortality disparities across races, counties, and race-counties in the United States. PLoS Med (2006) 8.70
GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64
Fine-particulate air pollution and life expectancy in the United States. N Engl J Med (2009) 8.36
What has made the population of Japan healthy? Lancet (2011) 8.18
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet (2005) 6.63
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.50
Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet (2007) 6.45
UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11
Global sodium consumption and death from cardiovascular causes. N Engl J Med (2014) 5.83
Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet (2011) 5.13
Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis (2007) 4.87
Stillbirths: the way forward in high-income countries. Lancet (2011) 4.69
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60
Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med (2007) 4.51
Exposure assessment for estimation of the global burden of disease attributable to outdoor air pollution. Environ Sci Technol (2012) 4.44
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet (2016) 4.29
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet (2006) 4.26
Inequalities in non-communicable diseases and effective responses. Lancet (2013) 4.18
Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet (2007) 4.15
National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr (2012) 4.13